FDA RFID Compliance: McKesson Supports FDA Compliance Policy on Radio Frequency ...

From Business Wire (press release), CA ... NYSE:MCK) today announced its strong support for the US Food and Drug Administration's initiative employing Radio Frequency Identification (RFID) technology to ...

... McKesson Corporation (NYSE:MCK) today announced its strong support for the US Food and Drug Administration's initiative employing Radio Frequency Identification (RFID) technology to create an electronic pedigree for pharmaceutical products. By using RFID technology to create an "electronic pedigree" -- a sort of living history of when and where the product was manufactured, its expiration date, when it was shipped, as well as its intended destination -- drugs can be tracked from factory to pharmacy, greatly reducing the chances of counterfeit products making their way into the supply chain. In addition, RFID tagging will allow for more rapid and accurate recalls, improve distributors' operational efficiencies and assist manufacturers, distributors, retailers and institutions in managing their inventories. ...

McKesson Corporation, ranked 16 on the Fortune 500, is a healthcare services and information technology company dedicated to helping its customers deliver high-quality healthcare by reducing costs, streamlining processes and improving the quality and safety of patient care. Over the course of its 170-year history, McKesson has grown to provide pharmaceutical and medical-surgical supply management across the spectrum of care; healthcare information technology for hospitals, physicians, homecare and payors; hospital and retail pharmacy automation; and services for manufacturers and payors designed to improve outcomes for patients.